Scientific Program

Scientific Program

The 13th World Stroke Congress will bring the latest science, clinical trials and guidelines to
stroke prevention, treatment, rehabilitation, and support, from every part of the globe.

The preliminary program of WSC 2021 is online. Click on the buttons below to see all the confirmed sessions.

*Updated as of 18 October 2021.

** The program is subject to change.

Program Highlights

28 October 2021, 12:00 – 13:30 CEST

Opening, Awards and Late Breaking Clinical Trials

WSO Award for Contributions to Clinical Research

Speaker: Mayowa Owolabi, Nigeria

WSO Award for Stroke Services

Introduction: Werner Hacke, Germany

Speaker: Thomas Fischer, Germany

WSO President’s Award

Introduction: Marc Fisher, USA

Speaker: Philip Bath, UK

Late Breaking Clinical Trials


28 October 2021, 19:15 – 20:45 CEST

Prehospital Stroke Care


James Grotta, USA

Natalia Perez de la Ossa, Spain

Latest Trial Results from BEST-MSU 

Speaker: James Grotta, USA

PRESTO Consortium: New Studies Going Forward

Speaker: Heirich Audebert, Germany

Prehospital Triage for Large Vessel Occlusion

Speaker: Alexandra Czap, USA

Prehospital Strategies for Brain Hemorrhage Management 

Speaker: Stephen Davis, Australia

Implementation of Mobile Stroke Units in Developing Countries 

Speaker: Yongchai Nilanont, Thailand


29 October 2021, 11:30 – 13:00 CEST

Stroke in Low to Middle Income Countries


Norlinah Ibrahim, Malaysia

Mayowa Owolabi, Nigeria

Overview of the Lancet Commission

Speaker: Mayowa Owolabi, Nigeria

The Changing World Landscape in Stroke Epidemiology

Speaker: Nijasri Suwanwela, Thailand

Economic Burden of Stroke

Speaker: Ajay Mahal, Australia

Realistic and Aspirational Stroke Prevention Goals

Speaker: Valery Feigin, New Zealand

Challenges in Delivering Comprehensive Stroke Care

Speaker: Jeyaraj Pandian, India

28 October 2021, 8:00 – 9:30 CEST

COVID Thrombosis and Stroke

How COVID 19 Impacted Stroke Services

Does COVID-19 Really Cause Stroke, What Types and Why?

COVID Vaccine Related Thrombosis


28 October 2021, 8:00 – 9:30 CEST

Establishing Stroke Services in Low and Middle Income Countries

Establishing Stroke Systems of Care from the Bottom to the Top: A Global Perspective

Improving Stroke Systems of Care in LMIC:


Sri Lanka




28 October 2021, 10:00 – 11:30 CEST


CT scan for Treatment Selection in Acute Ischemic Strokes

CT Perfusion in Acute Ischemic Stroke: Interpretation and Pitfalls

MRI in Acute Ischemic Stroke Within and Beyond the Established Time Windows

Portable MRI: What’s Possible Now and What’s Coming


28 October 2021, 10:00 – 11:30 CEST

Stroke Action Plans Around the World

European Stroke Action Plan

American Stroke Association 2030 Goals

China’s National Stroke Plan

Africa’s National Stroke Plan


28 October 2021, 15:45 – 17:15 CEST

Emerging Treatments for Brain Hemorrhage

Pro-coagulants in Hyperacute Phase of ICH

Stereotactic Minimally Invasive Evacuation 

Upcoming Treatment Approaches from Bench to Bedside

Blood Pressure Control after ICH


28 October 2021, 15:45 – 17:15 CEST

Implementation of Guidelines in Clinical Practice

Development of Guidelines: How Implementation is Considered

Working with the Government

The Role of Patients’ Organizations

Scientific Societies Contribution: Get with the Guidelines


28 October 2021, 17:45 – 19:15 CEST

Enhancing Stroke Care with Artificial Intelligence

Automated Evaluation of Acute Stroke Imaging

Clinical Decision Tools for Hospitalized Stroke Care

Neurocritical Care and AI

Stroke Recovery – ENIGMA 

Imaging, AI and Prediction of Recovery


29 October 2021, 8:00 – 9:30 CEST

Latest Advances in Recovery and Rehabilitation

Prognostic Modeling and Algorithms for Arm Impairment

Vagal Nerve Stimulation for Motor Recovery


Cell-based Regenerative Therapies


29 October 2021, 8:00 – 9:30 CEST

Neuropsychiatric Symptoms of Stroke: An Update

Psychological and Psychiatric Triggers and Risk Factors for Stroke

Post-stroke Delirium

Post-stroke Depression, Apathy and Anxiety

Neuropsychiatric Symptoms of CADASIL


29 October 2021, 10:00 – 11:30 CEST

Cerebral Small Vessel Diseases and Vascular Cognitive Impairment: A New WSO Task Force on Major Understudied Brain Conditions

Global Pandemics Require a Global Taskforce: The Aims of the cSVD & VCI Taskforce in WSO

cSVD/VCI in Developing Countries: What do we Know, What do we Need to Learn?

Neurology and Neuroradiology Collaborations to Detect cSVD

Lessons from Cardiology to Reduce cSVD/VCI Risks


29 October 2021, 10:00 – 11:30 CEST

Transient Ischemic Attacks: Where are we ?  

Models of TIA Care

New Diagnostic Tools

Risk of Transient Neurological Symptoms

Treatment Update


29 October 2021, 15:15 – 16:45 CEST

Vascular Cognitive Impairment

Vascular Cognitive Impairment: When and How to Screen in Clinical Practice?

Predicting Dementia After Stroke

Biomarkers of Vascular Cognitive Impairment

Mixed Dementia: Inter-relationships of Vessel and AD Pathology


29 October 2021, 17:15 – 18:45 CEST

Big Data and Public Health Initiatives

COVID-19 Registry Datasets


Eastern Europe

Clinical Application of Large Datasets


29 October 2021, 17:15 – 18:45 CEST

Future Directions in Stroke Therapy Development

Intra-arterial Therapy Development in Stroke Pig Models

Molecular Imaging

The Potential Therapeutic Applications of Microvessicles

Emerging Concepts from Basic Science

Gut-brain Axis and NeuroInflammation

Satellite RAISE Sessions

28 October 2021, 15:00 – 16:30 CEST

New Frontiers in Neurocardiology in 2020s

The Role of the Neurologist in the Management of Neurocardiologic Conditions

Advances in Atrial Fibrillation Detection

Left Atrial Appendage Closure: From RCTs to Worldwide Implementation

PFOs: To Close of Not to Close


28 October 2021, 17:00 – 18:30 CEST

Health Care Delivery Models and Transitions of Care

Transitions of Care after Stroke: Who, Where, and When?

Community-based Interventions for Management of Stroke Risk Factors

Post-stroke Care in Subsaharan Africa. Utilization of MHealth and Implications for Optimization of Care Delivery in Under-resourced Populations

The Impact of Social Determinants of Health on Transitions of Care and Post-Stroke Care


Satellite TTST Sessions

29 October 2021, 15:15 – 16:45 CEST

Future of IVT

Future of Tenecteplase

Future of IVT in Patients with LVO

Future of IVT Beyond 4,5 Hours

Future Guidelines on IV Treatment


29 October 2021, 17:15 – 18:45 CEST

Stroke Logistics Beyond Borders



Role of Prehospital CT-Ambulance

Role of Remove Proctoring in EVT

Hear from the Scientific Program Committee Co-chair – Ana Catarina Fonseca
why you should join the Virtual Congress and learn more about the scientific program.